Literature DB >> 3243733

Resistance of bacterial pathogens to four aminoglycosides and six other antibacterials and prevalence of aminoglycoside modifying enzymes, in 20 UK centres.

A M Lovering1, M J Bywater, H A Holt, H M Champion, D S Reeves.   

Abstract

A total of 5116 non-fastidious bacterial strains isolated from either blood or urine culture were collected from 20 geographically distributed centres within the UK. Upon receipt the strains were identified and the minimum inhibitory concentrations of ten antimicrobial agents in hospital usage were determined for each of the strains. All laboratories submitted a similar range of bacterial species and in species normally considered as sensitive the overall rates of resistance to the different antibiotics tested were: amikacin 2.4%, gentamicin 3.7%, netilmicin 2.6%, tobramycin 3.4%, ampicillin 41.7%, cefadroxil 11.6%, cefotaxime 1.4% [corrected], cefuroxime 4.3%, ciprofloxacin 0.6% and trimethoprim 13.0%. For those strains resistant to one or more aminoglycosides the mechanisms of resistance responsible were determined from the aminoglycoside-resistance patterns of the strains to 16 different aminoglycoside antibiotics. The predominant mechanisms of resistance found were APH(2") + AAC(6') production in staphylococci. AAC(2') production in Providencia spp., and AAC(3) production in the other Gram-negative genera.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3243733     DOI: 10.1093/jac/22.6.823

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  F Martineau; F J Picard; N Lansac; C Ménard; P H Roy; M Ouellette; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 2.  Bacterial challenges and evolving antibacterial drug strategy.

Authors:  B Watt; J G Collee
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

3.  Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates.

Authors:  K J Shaw; R S Hare; F J Sabatelli; M Rizzo; C A Cramer; L Naples; S Kocsi; H Munayyer; P Mann; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 4.  The penicillins today.

Authors:  R Finch
Journal:  BMJ       Date:  1990-05-19

Review 5.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 6.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 7.  Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: a review.

Authors:  D S Reeves
Journal:  Infection       Date:  1992       Impact factor: 3.553

8.  Antibiotic Susceptibility, Virulence Pattern, and Typing of Staphylococcus aureus Strains Isolated From Variety of Infections in India.

Authors:  Shifu Aggarwal; Smrutiti Jena; Sasmita Panda; Savitri Sharma; Benu Dhawan; Gopal Nath; N P Singh; Kinshuk Chandra Nayak; Durg Vijai Singh
Journal:  Front Microbiol       Date:  2019-12-04       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.